New app aims to make gestational diabetes easier to handle

NCT ID NCT07372872

Recruiting now Symptom relief Sponsor: Hong Kong Metropolitan University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing a smartphone app called MyGlucoCare that provides personalized education, clinician support, and a peer group for women with gestational diabetes. About 30 pregnant women will use the app for 8 to 12 weeks. Researchers want to see if the app is practical and acceptable, and whether it helps improve blood sugar control and well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MyGlucoCare smartphone app
What this could lead to: If successful, this app could provide a practical, low-cost way for women with gestational diabetes to better manage their blood sugar and well-being during pregnancy.
What could go wrong: This is a very small, early feasibility study with only 30 participants and no comparison group. The app may not show clear benefits or may not work for all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES MELLITUS (GDM)

Contacts and locations

Locations

Hong Kong Metropolitan University
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.